Strong expression of ANGPT2, TIE1, and TEK mRNAs has been reported in cutaneous angiosarcomas [42], and Tie2 antagonists inhibit in vitro angiosarcoma cell survival and delay in vivo angiosarcoma tumor growth [43]. This evidence concerns the gene TIE1 and angiosarcoma.